These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2971 related articles for article (PubMed ID: 17296351)

  • 61. Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment.
    Zhou XC; Dowdy SC; Podratz KC; Jiang SW
    Gynecol Oncol; 2007 Oct; 107(1):143-53. PubMed ID: 17692907
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.
    Woodson K; O'Reilly KJ; Hanson JC; Nelson D; Walk EL; Tangrea JA
    J Urol; 2008 Feb; 179(2):508-11; discussion 511-2. PubMed ID: 18076912
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epigenome: a new target in cancer therapy.
    Giacinti L; Vici P; Lopez M
    Clin Ter; 2008; 159(5):347-60. PubMed ID: 18998037
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epigenetic targets in cancer epidemiology.
    Dumitrescu RG
    Methods Mol Biol; 2009; 471():457-67. PubMed ID: 19109794
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Epigenetics and cancer].
    Deltour S; Chopin V; Leprince D
    Med Sci (Paris); 2005 Apr; 21(4):405-11. PubMed ID: 15811306
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Global histone modification patterns predict risk of prostate cancer recurrence.
    Seligson DB; Horvath S; Shi T; Yu H; Tze S; Grunstein M; Kurdistani SK
    Nature; 2005 Jun; 435(7046):1262-6. PubMed ID: 15988529
    [TBL] [Abstract][Full Text] [Related]  

  • 67. DNA methylation changes in prostate cancer.
    Goering W; Kloth M; Schulz WA
    Methods Mol Biol; 2012; 863():47-66. PubMed ID: 22359287
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Chromatin epigenetic modifications in cancer generation].
    Arenas-Huertero F; Recillas-Targa F
    Gac Med Mex; 2002; 138(6):547-55. PubMed ID: 12532619
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnostic and therapeutic applications of epigenetics.
    Miyamoto K; Ushijima T
    Jpn J Clin Oncol; 2005 Jun; 35(6):293-301. PubMed ID: 15930038
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Genomic imprinting of insulin-like growth factor II in prostate cancer and its clinical significance].
    Liu ZW; Zhou FJ; Luo YM; Qin ZK; Wang DJ; Luo JH; Han H; Li YH; Wang H
    Ai Zheng; 2006 Jun; 25(6):765-70. PubMed ID: 16764778
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
    Paluszczak J; Baer-Dubowska W
    Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Epigenetics in human disease and prospects for epigenetic therapy.
    Egger G; Liang G; Aparicio A; Jones PA
    Nature; 2004 May; 429(6990):457-63. PubMed ID: 15164071
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The potential role of epigenetic therapy in multiple myeloma.
    Smith EM; Boyd K; Davies FE
    Br J Haematol; 2010 Mar; 148(5):702-13. PubMed ID: 19912222
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.
    Kauffman EC; Robinson VL; Stadler WM; Sokoloff MH; Rinker-Schaeffer CW
    J Urol; 2003 Mar; 169(3):1122-33. PubMed ID: 12576866
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Epigenetic silencing of 14-3-3sigma in cancer.
    Lodygin D; Hermeking H
    Semin Cancer Biol; 2006 Jun; 16(3):214-24. PubMed ID: 16698281
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Detection of DNA hypermethylation as a potential biomarker for prostate cancer].
    Tilandyová P; Kajo K; Kliment J; Plank L; Lasabová Z
    Klin Onkol; 2010; 23(5):293-9. PubMed ID: 21061679
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Acquired disorders and epigenetics].
    Ushijima T
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1645-9. PubMed ID: 20841925
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epigenetics in chronic lymphocytic leukemia.
    Raval A; Byrd JC; Plass C
    Semin Oncol; 2006 Apr; 33(2):157-66. PubMed ID: 16616062
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reproductive epigenetics.
    Kelly TL; Trasler JM
    Clin Genet; 2004 Apr; 65(4):247-60. PubMed ID: 15025714
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Innovative approaches to the clinical development of DNA methylation inhibitors as epigenetic remodeling drugs.
    Murgo AJ
    Semin Oncol; 2005 Oct; 32(5):458-64. PubMed ID: 16210086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 149.